We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...
We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...
An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading ...
With The Royal Marsden we work across several centres to take the results of our research rapidly into the clinic to develop better treatments for cancer patients. We’ve developed collaborations with ...
We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...
The Division of Cancer Biology studies the complex interplay of genes, proteins and biological processes that drive the development and growth of cancers. Understanding the many different biological ...
We provide exceptional opportunities for the best scientists, clinicians, and professional and administrative staff, and excellent academic facilities.
The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact ...
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...
The annual leave entitlement is 28 days upon entry, rising to 29 days after 2 complete years of service, then to 30 days after 5 complete years of service. In addition, employees have an entitlement ...
Our multidisciplinary centres of excellence and strategic collaborations bring a critical mass of leading researchers together from across the ICR, The Royal Marsden and partner institutions to tackle ...